Literature DB >> 25855382

PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus-Induced Liver Carcinogenesis.

Hao Zhang1, Ahmed Diab1, Huitao Fan1, Saravana Kumar Kailasam Mani1, Ronald Hullinger1, Philippe Merle2, Ourania Andrisani3.   

Abstract

Elucidating mechanisms of hepatitis B virus (HBV)-mediated hepatocarcinogenesis is needed to gain insights into the etiology and treatment of liver cancer. Cells where HBV is replicating exhibit increased expression of Plk1 kinase and reduced levels of two transcription repression factors, SUZ12 and ZNF198. SUZ12 is an essential subunit of the transcription repressive complex PRC2. ZNF198 stabilizes the transcription repressive complex composed of LSD1, Co-REST, and HDAC1. These two transcription repressive complexes are held together by binding the long noncoding RNA HOTAIR. In this study, we linked these regulatory events mechanistically by showing that Plk1 induces proteasomal degradation of SUZ12 and ZNF198 by site-specific phosphorylation. Plk1-dependent ubiquitination of SUZ12 and ZNF198 was enhanced by expression of HOTAIR, significantly reducing SUZ12 and ZNF198 stability. In cells expressing the HBV X protein (HBx), downregulation of SUZ12 and ZNF198 mediated global changes in histone modifications. In turn, HBx-expressing cells propagated an altered chromatin landscape after cell division, as exemplified by changes in histone modifications of the EpCAM promoter, a target of PRC2 and LSD1/Co-REST/HDAC1 complexes. Notably, liver tumors from X/c-myc bitransgenic mice exhibited downregulation of SUZ12 and ZNF198 along with elevated expression of Plk1, HOTAIR, and EpCAM. Clinically, similar effects were documented in a set of HBV-related liver tumors consistent with the likelihood that downregulation of SUZ12 and ZNF198 leads to epigenetic reprogramming of infected hepatocytes. Because both Plk1 and HOTAIR are elevated in many human cancers, we propose that their combined effects are involved in epigenetic reprogramming associated broadly with oncogenic transformation. ©2015 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25855382      PMCID: PMC4452430          DOI: 10.1158/0008-5472.CAN-14-2928

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Phosphorylation of histone H3 is required for proper chromosome condensation and segregation.

Authors:  Y Wei; L Yu; J Bowen; M A Gorovsky; C D Allis
Journal:  Cell       Date:  1999-04-02       Impact factor: 41.582

2.  Differential immediate early gene expression in conditional hepatitis B virus pX-transforming versus nontransforming hepatocyte cell lines.

Authors:  C Tarn; M L Bilodeau; R L Hullinger; O M Andrisani
Journal:  J Biol Chem       Date:  1999-01-22       Impact factor: 5.157

3.  Inducible expression of human hepatitis B virus (HBV) in stably transfected hepatoblastoma cells: a novel system for screening potential inhibitors of HBV replication.

Authors:  S K Ladner; M J Otto; C S Barker; K Zaifert; G H Wang; J T Guo; C Seeger; R W King
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

4.  The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice.

Authors:  O Terradillos; O Billet; C A Renard; R Levy; T Molina; P Briand; M A Buendia
Journal:  Oncogene       Date:  1997-01-30       Impact factor: 9.867

Review 5.  The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis (Review).

Authors:  O M Andrisani; S Barnabas
Journal:  Int J Oncol       Date:  1999-08       Impact factor: 5.650

6.  Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas.

Authors:  Q Su; C H Schröder; W J Hofmann; G Otto; R Pichlmayr; P Bannasch
Journal:  Hepatology       Date:  1998-04       Impact factor: 17.425

7.  FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome.

Authors:  S Xiao; S R Nalabolu; J C Aster; J Ma; L Abruzzo; E S Jaffe; R Stone; S M Weissman; T J Hudson; J A Fletcher
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

8.  Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.

Authors:  T M Hagen; S Huang; J Curnutte; P Fowler; V Martinez; C M Wehr; B N Ames; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

9.  Woodchuck hepatitis virus X protein is required for viral infection in vivo.

Authors:  F Zoulim; J Saputelli; C Seeger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Sorafenib in advanced hepatocellular carcinoma.

Authors:  Josep M Llovet; Sergio Ricci; Vincenzo Mazzaferro; Philip Hilgard; Edward Gane; Jean-Frédéric Blanc; Andre Cosme de Oliveira; Armando Santoro; Jean-Luc Raoul; Alejandro Forner; Myron Schwartz; Camillo Porta; Stefan Zeuzem; Luigi Bolondi; Tim F Greten; Peter R Galle; Jean-François Seitz; Ivan Borbath; Dieter Häussinger; Tom Giannaris; Minghua Shan; Marius Moscovici; Dimitris Voliotis; Jordi Bruix
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

View more
  53 in total

1.  Polo-like-kinase 1 is a proviral host factor for hepatitis B virus replication.

Authors:  Ahmed Diab; Adrien Foca; Floriane Fusil; Thomas Lahlali; Pascal Jalaguier; Fouzia Amirache; Lia N'Guyen; Nathalie Isorce; François-Loïc Cosset; Fabien Zoulim; Ourania Andrisani; David Durantel
Journal:  Hepatology       Date:  2017-11-06       Impact factor: 17.425

2.  The Global Phosphorylation Landscape of SARS-CoV-2 Infection.

Authors:  Mehdi Bouhaddou; Danish Memon; Bjoern Meyer; Kris M White; Veronica V Rezelj; Miguel Correa Marrero; Benjamin J Polacco; James E Melnyk; Svenja Ulferts; Robyn M Kaake; Jyoti Batra; Alicia L Richards; Erica Stevenson; David E Gordon; Ajda Rojc; Kirsten Obernier; Jacqueline M Fabius; Margaret Soucheray; Lisa Miorin; Elena Moreno; Cassandra Koh; Quang Dinh Tran; Alexandra Hardy; Rémy Robinot; Thomas Vallet; Benjamin E Nilsson-Payant; Claudia Hernandez-Armenta; Alistair Dunham; Sebastian Weigang; Julian Knerr; Maya Modak; Diego Quintero; Yuan Zhou; Aurelien Dugourd; Alberto Valdeolivas; Trupti Patil; Qiongyu Li; Ruth Hüttenhain; Merve Cakir; Monita Muralidharan; Minkyu Kim; Gwendolyn Jang; Beril Tutuncuoglu; Joseph Hiatt; Jeffrey Z Guo; Jiewei Xu; Sophia Bouhaddou; Christopher J P Mathy; Anna Gaulton; Emma J Manners; Eloy Félix; Ying Shi; Marisa Goff; Jean K Lim; Timothy McBride; Michael C O'Neal; Yiming Cai; Jason C J Chang; David J Broadhurst; Saker Klippsten; Emmie De Wit; Andrew R Leach; Tanja Kortemme; Brian Shoichet; Melanie Ott; Julio Saez-Rodriguez; Benjamin R tenOever; R Dyche Mullins; Elizabeth R Fischer; Georg Kochs; Robert Grosse; Adolfo García-Sastre; Marco Vignuzzi; Jeffery R Johnson; Kevan M Shokat; Danielle L Swaney; Pedro Beltrao; Nevan J Krogan
Journal:  Cell       Date:  2020-06-28       Impact factor: 41.582

3.  Long non-coding RNA IRAIN suppresses apoptosis and promotes proliferation by binding to LSD1 and EZH2 in pancreatic cancer.

Authors:  Yifan Lian; Juan Wang; Jing Feng; Jie Ding; Zhonghua Ma; Juan Li; Peng Peng; Wei De; Keming Wang
Journal:  Tumour Biol       Date:  2016-09-19

4.  EpCAM-regulated intramembrane proteolysis induces a cancer stem cell-like gene signature in hepatitis B virus-infected hepatocytes.

Authors:  Saravana Kumar Kailasam Mani; Hao Zhang; Ahmed Diab; Pete E Pascuzzi; Lydie Lefrançois; Nadim Fares; Brigitte Bancel; Philippe Merle; Ourania Andrisani
Journal:  J Hepatol       Date:  2016-05-26       Impact factor: 25.083

5.  Interferon signaling during Hepatitis B Virus (HBV) infection and HBV-associated hepatocellular carcinoma.

Authors:  Saravana Kumar Kailasam Mani; Ourania Andrisani
Journal:  Cytokine       Date:  2018-08-17       Impact factor: 3.861

Review 6.  LncRNA HOTAIR: A master regulator of chromatin dynamics and cancer.

Authors:  Arunoday Bhan; Subhrangsu S Mandal
Journal:  Biochim Biophys Acta       Date:  2015-07-21

7.  HOTAIR is a predictive and prognostic biomarker for patients with advanced gastric adenocarcinoma receiving fluorouracil and platinum combination chemotherapy.

Authors:  Wei Zhao; Shuang Dong; Bensong Duan; Ping Chen; Lei Shi; Hengjun Gao; Haizhi Qi
Journal:  Am J Transl Res       Date:  2015-07-15       Impact factor: 4.060

8.  HBx/ERα complex-mediated LINC01352 downregulation promotes HBV-related hepatocellular carcinoma via the miR-135b-APC axis.

Authors:  Pinbo Huang; Qiaodong Xu; Yongcong Yan; Yingjuan Lu; Zhigang Hu; Bing Ou; Heyun Zhang; Kai Mao; Jianlong Zhang; Jie Wang; Zhiyu Xiao
Journal:  Oncogene       Date:  2020-03-10       Impact factor: 9.867

9.  Plk1 phosphorylation of Numb leads to impaired DNA damage response.

Authors:  C Shao; S-J Chien; E Farah; Z Li; N Ahmad; X Liu
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

10.  GIAT4RA functions as a tumor suppressor in non-small cell lung cancer by counteracting Uchl3-mediated deubiquitination of LSH.

Authors:  Rui Yang; Na Liu; Ling Chen; Yiqun Jiang; Ying Shi; Chao Mao; Yating Liu; Min Wang; Weiwei Lai; Haosheng Tang; Menghui Gao; Desheng Xiao; Xiang Wang; Hu Zhou; Can-E Tang; Wenliang Liu; Fenglei Yu; Ya Cao; Qin Yan; Shuang Liu; Yongguang Tao
Journal:  Oncogene       Date:  2019-08-15       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.